Arvinas (ARVN)

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

{% set status = marketHours.currentMarketStatus if marketHours.currentMarketStatus == "pre-market" or marketHours.currentMarketStatus == "after-hours" %}{% set hasHighAndLow = tickerData.data[dynamicVariables.equity upper].high and tickerData.data[dynamicVariables.equity upper].low %}{% if resolvedDynamicVariables[dynamicVariables.equity].subclass == "stock" %} () 股票 今日價格為 ，自市場 {% if status %} 上次收盤 {% else %} 開盤以來錄得 變動。該公司的市值為 ，日交易量為 股。{% if hasHighAndLow %}對於關注價格走勢的投資者而言， 股票今日的波動區間介於 和 之間。{% endif %} 上一個收盤價為 。{% else %} () ETF 今日價格為 。  ETF 當前 {% if resolvedDynamicVariables[dynamicVariables.equity].market_cap %} 市值為 ，{% endif %} 日交易量為 股。

{% if hasHighAndLow %}對於分析 ETF 表現的投資者而言， 當天的波動區間在 和 之間，前一交易日收盤價為 。透過這些資料可以深入了解近期的價格波動和流動性。{% endif %}

{% endif %}

是否準備好開始交易？請按照以下步驟操作，或閱讀我們的指南 如何在 Kraken 上購買 Arvinas 股票，起始金額為 $10。